Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2015 Jul 23;14(10):2249–2259. doi: 10.1158/1535-7163.MCT-15-0429

Figure 1. Investigation of CGM097 against human AML cell lines expressing either wt or mutant p53.

Figure 1

(A) Chemical structure of CGM097. Effects of CGM097 treatment on proliferation (B), apoptosis (C), and cell cycle progression (D) following approximately three days of treatment. (C–D) Bar graphs are representative of apoptosis and cell cycle data shown in Supplementary Figures 2 and 3, respectively.